Global Health

“ACT Consortium” Pools Top Multinational Brains To Implement Artemisinin Combinations In Malaria

November 16, 2009
Anthony Mbonye

Anthony Mbonye

Ugandan Health Ministry Commissioner Dr Anthony Mbonye and London School of Hygiene and Tropical Medicine scientist Professor David Schellenberg are just two of the multinational members of the recently-formed ACT consortium set up to pool the expertise of leading scientists and public health movers and shakers in both the developed and developing world to fight malaria with optimal use of the best drugs: artemisinin combination treatments, or ACTs. After a symposium devoted to the work of the new consortium—held at the Multilateral Initiative on Malaria Pan African Malaria Conference held in Nairobi—they talked about their current programme and the goals in sight.

Download this interview

Add podcast to iTunes

Similar Interviews

  • Consortium To Optimise World Use Of Artemisinin Combination Treatments For Malaria

    • [caption id="attachment_1038" align="alignnone" width="120" caption="Bianca D'Souza"][/caption] During the 5th Multilateral Initiative On Malaria Pan African Malaria Conference held in Nairobi,

  • “ACT Consortum” Investigates Millions of Lives At Stake From Substandard, Degraded And Fake Anti-Malarial Drugs

    • [caption id="attachment_1034" align="alignnone" width="120" caption="Harparkash Kaur"][/caption] The problem of artemisinin combination treatments (ACTs) in malaria which are ineffective because of

    • The London School of Hygiene And Tropical Medicine's Audio News reports from the 5th Multilateral Initiative On Malaria Pan African

    Post a comment